Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Exhibition > Immuno-Oncology 2021
  1. Immuno-Oncology 2021

    1. JUN 2, 2021 Opens: 6:00 AM PDT
    2. Online
    3. Michael A. Curran, PhD, Adam Burrack, M.S., Ph.D., Gordon J. Freeman, PhD etc.
    ACROBio is proud to sponsor at Immuno-Oncology 2021.
    Click the button to enter our raffle.
  2. ACROBiosystems is pleased to announce the inauguration of the Immuno-Oncology Virtual Event taking place on June 2, 2021. Immuno-Oncology is considered by some to be one of the most promising areas of research in the world of anti-cancer therapeutics. Learn from experts how immunotherapies can work alone, together, or in combination with other treatments to fight cancer.

     

    This year's event includes the following tracks and topics:

     

    New Advancements in Immuno-Oncology

    ·         Cell Therapy Innovation

    ·         Checkpoint Inhibitors

    ·         Innate Immunity Considerations

    ·         Microbiome and Cancer

    ·         New Adaptive Immunity Considerations

     

    Emerging Targets for Immuno-Oncology Therapy

    ·         Overcoming Obstacles in the Immunosuppressive Tumor Micro-environment

    ·         Molecular and Epigenetic Modulation

    ·         Cancer Immunotherapeutics and COVID-19

    ·         Novel Cell Therapy Targets and Engineering Strategies

     

    Advancing Cancer Immunotherapies to the Clinic

    ·         Translational

    ·         Clinical

     

     

    Register nowhttps://www.labroots.com/register/immuno-oncology-2021

     

    Meet the speakers (partial):

    teacher1.jpg

    teacher2.jpg

New & Hot Products


This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message